Nkarta’s AML Update Disappoints, But New Conditioning Regimen Might Improve Response

An awaited update on early data for a CAR-NK therapeutic shows disappointing efficacy and duration, but a different chemotherapy conditioning regimen for lymphodepletion is showing early promise in acute myeloid leukemia.